1Kitawaki J, Kado N, Ishihara H, et al. Endometriosis : the pathophysiology as an estrogen-dependent disease [ J ]. J Steroid Biochem Mol Biol,2002,83 : 149-155
2Kusuki I, Kitawaki J, Ishihara H, et al. Immunohistochemical localization of aromatase and apoptosis-associated proteins in ovarian serous cystadenocarcinoma arising from ovarian endometriosis[J]. Eur J Obstet Gynecol Reprod Biol,2001,98 : 114-118
3Boccardo F, Rubagotti A, Aldrighetti D, et al. Switching to an aromatase inhibitor provides mortality benefit in early breast carcinoma: pooled analysis of 2 consecutive trials [ J ]. Cancer,2007,109 : 1060-1067
4Gibson LJ, Dawson C, Lawrence D J, et al. Aromatase inhibitors for treatment of advanced breast cancer in postmenopausal women[ J ]. Cochrane Database Syst Rev ,2007, 24 : CD003370
5Yang HJ, Shozu M, Murakami K, et al. Spatially heterogenous expression of aromatase P450 through promoter Ⅱ Is closely correlated with the level of steroidogenic factor-1 transcript in endometrioma tissues [ J ]. J Clin Endocrinol Metab, 2002,87 : 3745-3753
7Velasco I, Rueda J, Acien P. Aromatase expression in endometriotic tissues and cell cultures of patients with endometriosis [ J ]. Mol Hum Reprod, 2006,12 : 377-381
9Matsuzaki S, Canis M, Pouly JL, et al. Analysis of aromatase and 17beta-hydroxysteroid dehydrogenase type 2 messenger ribonucleic acid expression in deep endometriosis and eutopic endometrium using laser capture microdissection [ J ]. Fertil Steril,2006 ,85 :308-313
10Fang Z, Yang S, Gurates B, et al. Genetic or enzymatic disruption of aromatase inhibits the growth of ectopic uterine tissue [ J ]. J Clin Endocrinol Metab, 2002, 87 : 3460-3466
二级参考文献14
1Simpson E,Rubin G,Clyne C,et al.The role of local estrogen biosynthesis in males and females.Trends Endocrinol Metab,2000,11(5):184-188
2Lonning PE.Aromatase inhibitors and inactivators in breast cancer.BMJ,2001,323:880-881
3Simpson ER,Clyne C,Speed C,et al.Tissug-specific estrogen biosynthesis and metabolism.Ann N Y Acad Sci,2001,949:58-67
4Miller WR,Dixon JM.Endocrine and clinical endpoints of exemestane as neoadjuvant theapy.Cancer Control,2002,9[2 Suppl]:9-15
5Goss P.Anti-aromatase agents in the treatment and prevention of breast cancer.Cancer Control,2002,9[2 Suppl]:2-8
7Kitawaki J, Kusuki I, Koshiba H, et al. Expression of aromatase cytochrome P450 in eutopic endometrium and its application as a diagnostic test for endometriosis. Gynecol Obstet Invest, 1999,48 Suppl 1:21-28.
8Jiang J,Wu RF, Wang ZH, et al. Effect of mifepristone on estrogen and progesterone receptors in human endometrial and endometriotic cells in vitro. Fertil Steril, 2002,77:995-1000.
9Bulun SE, Zeitoun KM, Takayama K, et al. Estrogen biosynthesis in ensometriosis: molecular basis and clinical relevance. J Mol Endocrinol, 2000,25:35-42.
10Kitawaki J, Kusuki I, Koshiba H, et al. Detection of aromatase cytochrome P450 in endometrial biopsy specimens as a diagnostic test for endometriosis. Fertil Steril, 1999,72:1100-1106.
